Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Probiotics for Crohn's disease: what have we learned?

Literature DB >> 16698749

Probiotics for Crohn's disease: what have we learned?

C Prantera¹.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 16698749 PMCID： PMC1856223 DOI： 10.1136/gut.2005.085381

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

28 in total

1. Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad.

Authors: W A Faubion; W J Sandborn
Journal: Gastroenterology Date: 2000-03 Impact factor: 22.682

2. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors: P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal: Gastroenterology Date: 2000-08 Impact factor: 22.682

3. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers.

Authors:
Journal: J Travel Med Date: 1997-03-01 Impact factor: 8.490

4. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.

Authors: Arnoldo J Riquelme; Mario A Calvo; Ana M Guzmán; María S Depix; Patricia García; Carlos Pérez; Marco Arrese; Jaime A Labarca
Journal: J Clin Gastroenterol Date: 2003-01 Impact factor: 3.062

5. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

Authors: H A Malchow
Journal: J Clin Gastroenterol Date: 1997-12 Impact factor: 3.062

6. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.

Authors: W Kruis; E Schütz; P Fric; B Fixa; G Judmaier; M Stolte
Journal: Aliment Pharmacol Ther Date: 1997-10 Impact factor: 8.171

7. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome.

Authors: Mary Ann De Groote; Daniel N Frank; Elaine Dowell; Mary P Glode; Norman R Pace
Journal: Pediatr Infect Dis J Date: 2005-03 Impact factor: 2.129

8. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors: Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal: Gastroenterology Date: 2003-05 Impact factor: 22.682

9. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus.

Authors: J M Saavedra; N A Bauman; I Oung; J A Perman; R H Yolken
Journal: Lancet Date: 1994-10-15 Impact factor: 79.321

10. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor.

Authors: D Hollander; C M Vadheim; E Brettholz; G M Petersen; T Delahunty; J I Rotter
Journal: Ann Intern Med Date: 1986-12 Impact factor: 25.391

5 in total

Review 1. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.

Authors: Josef R Bober; Chase L Beisel; Nikhil U Nair
Journal: Annu Rev Biomed Eng Date: 2018-03-12 Impact factor: 9.590

Review 2. A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors: David Kim; Sasha Taleban
Journal: Drugs Aging Date: 2019-07 Impact factor: 3.923